TBPH
Theravance Biopharma Inc
NASDAQ: TBPH · HEALTHCARE · BIOTECHNOLOGY
$17.03
+0.00% today
Updated 2026-09-25
Market cap
$884.18M
P/E ratio
16.38
P/S ratio
8.48x
EPS (TTM)
$1.04
Dividend yield
—
52W range
$13 – $21
Volume
0.8M
Theravance Biopharma Inc (TBPH) Insider transactions
Net insider activity
Net selling (209,834 shares)
Buy transactions
39
Sell transactions
61
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 6,657 | $17.03 | $113396.67 |
| 2026-09-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 3,329 | $17.03 | $56706.52 |
| 2026-09-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 3,328 | $17.03 | $56690.15 |
| 2026-08-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 20,034 | $16.95 | $339576.30 |
| 2026-08-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 8,112 | $16.95 | $137498.40 |
| 2026-08-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 6,258 | $16.95 | $106073.10 |
| 2026-08-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 7,952 | $16.95 | $134786.40 |
| 2026-08-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 5,667 | $16.95 | $96055.65 |
| 2026-07-07 | SAMAHA, ELI | 10% Owner | Sale | 5,564 | $17.17 | $95540.56 |
| 2026-07-06 | SAMAHA, ELI | 10% Owner | Sale | 1,400 | $17.04 | $23856.00 |
| 2026-07-01 | SAMAHA, ELI | 10% Owner | Sale | 37,799 | $17.00 | $642628.36 |
| 2026-06-30 | SAMAHA, ELI | 10% Owner | Sale | 25,027 | $17.13 | $428787.59 |
| 2026-06-29 | SAMAHA, ELI | 10% Owner | Sale | 273,871 | $17.23 | $4.72M |
| 2026-06-19 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Buy | 18,750 | — | — |
| 2026-06-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 6,657 | $16.39 | $109078.94 |
| 2026-06-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 3,329 | $16.39 | $54562.98 |
| 2026-06-15 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 3,328 | $16.38 | $54525.29 |
| 2026-06-12 | SMALDONE, ALSUP LAURIE | Director | Buy | 13,398 | — | — |
| 2026-06-12 | SMALDONE, ALSUP LAURIE | Director | Buy | 6,009 | — | — |
| 2026-06-12 | PAKIANATHAN, DEEPIKA | Director | Buy | 13,398 | — | — |
| 2026-06-12 | PAKIANATHAN, DEEPIKA | Director | Buy | 6,009 | — | — |
| 2026-06-12 | O'CONNOR, DONAL | Director | Buy | 13,398 | — | — |
| 2026-06-12 | O'CONNOR, DONAL | Director | Buy | 6,009 | — | — |
| 2026-06-12 | MITCHELL, DEAN J | Director | Buy | 13,398 | — | — |
| 2026-06-12 | MITCHELL, DEAN J | Director | Buy | 6,009 | — | — |
| 2026-06-12 | GRAY, SUSANNAH | Director | Buy | 13,398 | — | — |
| 2026-06-12 | GRAY, SUSANNAH | Director | Buy | 6,009 | — | — |
| 2026-05-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 20,038 | $16.55 | $331628.90 |
| 2026-05-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 8,670 | $16.55 | $143488.50 |
| 2026-05-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 6,827 | $16.55 | $112986.85 |
| 2026-05-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 8,829 | $16.55 | $146119.95 |
| 2026-05-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 5,678 | $16.55 | $93970.90 |
| 2026-04-01 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Buy | 75,000 | — | — |
| 2026-04-01 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Buy | 37,500 | — | — |
| 2026-04-01 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Buy | 37,500 | — | — |
| 2026-04-01 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Buy | 18,750 | — | — |
| 2026-03-16 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 15,534 | $14.00 | $217476.00 |
| 2026-03-16 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 7,767 | $13.92 | $108087.90 |
| 2026-03-16 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 7,766 | $13.92 | $108073.21 |
| 2026-02-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 74,975 | $19.66 | $1.47M |
| 2026-02-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 20,672 | $19.66 | $406411.52 |
| 2026-02-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 16,851 | $19.66 | $331290.66 |
| 2026-02-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 20,833 | $19.66 | $409576.78 |
| 2026-02-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 13,929 | $19.66 | $273844.14 |
| 2025-12-03 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 15,534 | $18.75 | $291251.63 |
| 2025-12-03 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 7,767 | $18.75 | $145630.47 |
| 2025-12-03 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 7,766 | $18.75 | $145618.71 |
| 2025-11-26 | BROSHY, ERAN | Director | Buy | 14,000 | $10.15 | $142100.00 |
| 2025-11-26 | BROSHY, ERAN | Director | Sale | 15,501 | $20.00 | $310020.00 |
| 2025-11-26 | BROSHY, ERAN | Director | Sale | 14,000 | $20.00 | $280000.00 |
| 2025-11-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 56,817 | $17.90 | $1.02M |
| 2025-11-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 18,627 | $17.90 | $333423.30 |
| 2025-11-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 6,989 | $17.90 | $125103.10 |
| 2025-11-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 19,024 | $17.90 | $340529.60 |
| 2025-11-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 9,060 | $17.90 | $162174.00 |
| 2025-11-19 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Buy | 9,900 | — | — |
| 2025-11-11 | BROSHY, ERAN | Director | Buy | 14,000 | $10.15 | $142100.00 |
| 2025-11-11 | BROSHY, ERAN | Director | Sale | 29,500 | $18.50 | $545750.00 |
| 2025-11-11 | BROSHY, ERAN | Director | Sale | 15,500 | $18.50 | $286750.00 |
| 2025-11-11 | BROSHY, ERAN | Director | Sale | 14,000 | $18.50 | $259000.00 |
| 2025-08-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 15,394 | $13.39 | $206125.66 |
| 2025-08-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 9,368 | $13.39 | $125437.52 |
| 2025-08-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 6,989 | $13.39 | $93582.71 |
| 2025-08-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 9,762 | $13.39 | $130713.18 |
| 2025-08-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 9,096 | $13.39 | $121795.44 |
| 2025-07-14 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 5,318 | $11.39 | $60548.09 |
| 2025-07-14 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 4,000 | $11.39 | $45551.60 |
| 2025-07-14 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 682 | $11.39 | $7769.82 |
| 2025-06-23 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 20,000 | — | — |
| 2025-06-13 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Buy | 9,600 | — | — |
| 2025-06-02 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 24,000 | $11.00 | $264000.00 |
| 2025-05-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 15,364 | $9.45 | $145189.80 |
| 2025-05-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 9,348 | $9.45 | $88338.60 |
| 2025-05-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 9,701 | $9.45 | $91674.45 |
| 2025-05-20 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Sale | 9,743 | $9.45 | $92071.35 |
| 2025-05-20 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 9,120 | $9.45 | $86184.00 |
| 2025-05-19 | SMALDONE, ALSUP LAURIE | Director | Buy | 24,258 | — | — |
| 2025-05-19 | SMALDONE, ALSUP LAURIE | Director | Buy | 10,649 | — | — |
| 2025-05-19 | PAKIANATHAN, DEEPIKA | Director | Buy | 24,258 | — | — |
| 2025-05-19 | PAKIANATHAN, DEEPIKA | Director | Buy | 10,649 | — | — |
| 2025-05-19 | O'CONNOR, DONAL | Director | Buy | 24,258 | — | — |
| 2025-05-19 | O'CONNOR, DONAL | Director | Buy | 10,649 | — | — |
| 2025-05-19 | MITCHELL, DEAN J | Director | Buy | 24,258 | — | — |
| 2025-05-19 | MITCHELL, DEAN J | Director | Buy | 10,649 | — | — |
| 2025-05-19 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Buy | 10,430 | — | — |
| 2025-05-19 | GRAY, SUSANNAH | Director | Buy | 24,258 | — | — |
| 2025-05-19 | GRAY, SUSANNAH | Director | Buy | 10,649 | — | — |
| 2025-05-19 | GRANT, JEREMY T | Director | Buy | 24,258 | — | — |
| 2025-05-19 | GRANT, JEREMY T | Director | Buy | 10,649 | — | — |
| 2025-05-19 | BROSHY, ERAN | Director | Buy | 24,258 | — | — |
| 2025-05-19 | BROSHY, ERAN | Director | Buy | 10,649 | — | — |
| 2025-04-21 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Sale | 4,000 | $9.00 | $36000.00 |
| 2025-02-28 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Buy | 2,178 | $9.35 | $20364.30 |
| 2025-02-28 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Buy | 75,000 | — | — |
| 2025-02-28 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Buy | 75,000 | — | — |
| 2025-02-28 | GRIMAUD, BRETT A. | SVP, GEN COUNSEL AND SECRETARY | Buy | 75,000 | — | — |
| 2025-02-28 | FARNUM, RHONDA | SVP, COMM & MEDICAL AFFAIRS | Buy | 75,000 | — | — |
| 2025-02-20 | WINNINGHAM, RICK E | Director, CHIEF EXECUTIVE OFFICER | Sale | 35,129 | $9.66 | $339346.14 |
| 2025-02-20 | SAWAF, AZIZ | SVP & CHIEF FINANCIAL OFFICER | Sale | 13,751 | $9.66 | $132834.66 |
| 2025-02-20 | MILLER, AINE | SVP, DEV & HEAD OF IRE OFFICE | Sale | 11,295 | $9.66 | $109109.70 |
Frequently asked questions
Are TBPH insiders buying or selling?
Over the transactions on record, TBPH insiders have been net sellers, with about $17.75M in stock sold across 61 sales, against 3 open-market purchases.
Does insider selling at TBPH mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which TBPH insiders are selling the most?
Recent selling is concentrated in a few names. SAMAHA, ELI accounts for the largest share on record, with about $5.91M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.